Following the reversal of Roe vs Wade, Audrey Nath, MD, PhD, discusses its implications on neurologists and the standard neurologic care they provide for their patients.
Patients with AF with a high bleeding risk and a low stroke risk may benefit from LAAO over oral anticoagulation.
Aduhelm, a monoclonal antibody that targets amyloid-beta, is covered under Medicare for beneficiaries enrolled in clinical trials.
Looking at stress and university students during the COVID-19 pandemic.
New and improved to provide a more modern and readable format for the latest neurology news for today’s neurologists.
We spoke with Rebecca Edelmayer, PhD, the Alzheimer’s Association Senior Director of Scientific Engagement, about studies presented at the Alzheimer’s Association International Conference (AAIC) 2022 regarding individual’s life experiences and brain health.
The most common symptoms of monkeypox that have neurologic origins may also be related to infectious disease overall.
A biomarker for both ALS and FTD, 2 neurological disorders that share clinical, genetic, and pathological traits, can help signal disease onset and the progression of degeneration.
David Howell, PhD; and Heather Sesma, PhD; provide insight into the specific sequelae of concussion in youth and risk for subsequent mental health issues.